Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Abeona Therapeutics Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +6 vs. Q4 2025
- Shares held
- 39.5M
- +3.37M (+9.3%) vs. Q4 2025
- Total value
- $177.1M
- −$13.4M (−7.1%) vs. Q4 2025
- New holders
- 17
- 40 more added
- Sold out
- 11
- 33 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $243.3M |
| Q1 2026 | 108 | $177.1M |
| Q4 2025 | 104 | $205.2M |
| Q3 2025 | 100 | $187.9M |
| Q2 2025 | 95 | $198.2M |
| Q1 2025 | 71 | $141.2M |
| Q4 2024 | 65 | $170.4M |
| Q3 2024 | 55 | $181.7M |
| Q2 2024 | 48 | $127.8M |
| Q1 2024 | 56 | $104.7M |
| Q4 2023 | 48 | $70.8M |
| Q3 2023 | 40 | $52.5M |
| Q2 2023 | 37 | $37.9M |
| Q1 2023 | 33 | $21.2M |
| Q4 2022 | 41 | $28.5M |
| Q3 2022 | 25 | $3.62M |
| Q2 2022 | 44 | $4.51M |
| Q1 2022 | 56 | $10.3M |
| Q4 2021 | 53 | $13.7M |
| Q3 2021 | 60 | $28.3M |
| Q2 2021 | 73 | $43.4M |
| Q1 2021 | 78 | $58.4M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Abeona Therapeutics Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kennedy Capital Management, Inc. | 1,263,511 | $5.66M | 0.12% | +213,416+20.3% | Added |
| Propel Bio Management, LLC | 1,329,899 | $6.01M | 3.79% | +499,119+60.1% | Added |
| Vanguard Capital Management LLC | 2,164,851 | $9.70M | 0.00% | +2,164,851 | New |
| Suvretta Capital Management, LLC | 2,676,000 | $12.0M | 0.33% | 00.0% | Unchanged |
| Cable Car Capital LLC | 3,007,329 | $13.5M | 4.65% | +507,329+20.3% | Added |
| AIGH Capital Management LLC | 3,100,000 | $13.9M | 2.84% | +1,100,000+55.0% | Added |
| BlackRock, Inc. | 3,195,530 | $14.3M | 0.00% | +35,667+1.1% | Added |
| Nantahala Capital Management, LLC | 5,013,052 | $22.5M | 1.40% | +50,000+1.0% | Added |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −1,842,751−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −616,413−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −366,067−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −75,940−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −33,581−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −25,779−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −12,570−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −10,731−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,372−100.0% | Sold out |
| Vermillion & White Wealth Management Group, LLC | 0 | $0 | 0.00% | −370−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Sherbrooke Park Advisers LLC | – | – | – | – | Not filed |